Investing in patient-focused companies that have exceptional technologies, clear regulatory pathways to commercialization, and the potential to improve patient care. Hibiscus Capital Management selects companies based on strong investment conviction, leveraging the team’s industry experience and broad scientific relationships in the biotech and pharma space.
Aligning incentives for patients, management teams and investors. Working closely with the Hibiscus BioTechnology team to support the development of Studio Companies. Hibiscus Capital Management leverages Hibiscus BioTechnology’s operational expertise and diligence on new investment opportunities.